Abbvie to Acquire Allergan for $63 Billion
- Posted by ISPE Boston
- On July 11, 2019
AbbVie and Allergan announced that the companies have entered into a definitive transaction agreement under which AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity value of approximately $63 billion, based on the closing price of AbbVie’s common stock on June 24, 2019. “This is a transformational transaction for both […]
Read More